The Office of HIV/AIDS Network Coordination (HANC) works with the HIV/AIDS Clinical Trials Networks of the U.S. National Institutes of Health (NIH) with the intent of creating a more integrated, collaborative and flexible research structure. The networks are an affiliated group of national and international medical research institutions and investigators that conduct clinical HIV/AIDS research to develop safe and effective drugs, prevention strategies, and vaccines.
The HANC-facilitated COVID-19 CAB Coalition Work Group formed an ad-hoc work group to develop five scripts to help people better understand science and clinical research. For more information and to view the videos, click here.
The Office of HIV/AIDS Network Coordination (HANC) is recruiting for its next HANC Director. The HANC Director is responsible for managing and supervising all aspects of the activities of HANC, and reports to the principal investigators of the four NIH-funded HIV/AIDS Clinical Trial Networks and the Director of the Division of DAIDS at NIAID. View more details and apply on the Fred Hutch Careers page.
The Office of HIV/AIDS Network Coordination (HANC) programs are referred to as areas of coordination. Within each area of coordination are numerous work groups that are integral to advancing the research goals and objectives defined by the HIV/AIDS Clinical Trials Networks and the Division of AIDS.
HANC supports a number of trans-institute behavioral science groups composed of experts that are working to advance research and clinical trials through cross-network collaboration.
HANC supports Community Partners, The Legacy Project, and the COVID-19 CAB coalition to achieve representation and build relationships with historically underrepresented communities in clinical research.
HANC supports cross-network working groups for network leadership, communications, data management centers, performance evaluation, and site coordinators to promote greater information sharing, collaboration, and process standardization.
HANC supports several cross-network laboratory working groups and committees with the aim of harmonizing processes and procedures, ensuring standard quality assurance for protocol-specified assays and laboratory preparedness for network clinical trials.
The National Institute of Allergy and Infectious Diseases (NIAID) Division of AIDS (DAIDS), in partnership with other NIH Institutes and Centers, is planning a 2-day workshop entitled “3D Human Tissue Models for HIV and Related Comorbidities: How Can Organoids and Microphysiological Systems Advance the Field?”
This workshop will bring together experts in the HIV and non-HIV fields involved in research with 3D human tissue models to understand potential synergies of interest to academics, industry, and regulators. Through this workshop, we aim to bridge and understand the concepts, translational potential, and opportunities for 3D tissue models to advance basic and translational research for HIV and related comorbidities, including tuberculosis and substance use and dependence, across the age spectrum.
More information will be forthcoming.
Working together, we can be the generation to end the HIV/AIDS epidemic. Know the facts, spread the word, volunteer for a study, or join a community advisory board.